Site menu

Search by ticker code:
Generic filters

Menu

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Nanosonics (ASX:NAN) share price drops 16% – here’s why

The Nanosonics Ltd (ASX: NAN) share price has sunk as much as 16% this morning after announcing it would renegotiate its contract with major distributor GE.

The business also expects to report revenue a 41% jump in revenue to $60.6 million for the first half when it releases its result on February 22.

Currently, the Nanosonics share price is down 8.53% to $4.61.

Keep up to date with the February 2022 reporting season calendar.

Nanosonics designs and manufactures infection prevent equipment for hospitals and healthcare applications.

Change up for final five months

Nanosonics announced it would renegotiate its sales contract with GE for the remaining five months to June 30.

Per the current sales model, GE purchases inventory from Nanosonics. Then it sells equipment such as capital devices and consumables to end-users.

The revised model will see GE consume its existing inventory. Meanwhile, Nanosonics will take charge of inventory, shipping, installing and training.

Nanosonics also transition all existing GE customers to its business for the sale of consumables.

“During this transition, both companies will have a focus on ensuring a positive customer experience with no disruption in continuity of customer supply”

Why change the contract?

GE and Nanosonics are currently in the process of a new seller agreement from July 1 onwards.

It is expected that the new agreement will involve Nanosonics taking a larger role in selling and distribution.

Subsequently, GE wants to reduce its inventory of Nanosonics products before the contract is up.

Otherwise, it could be left with excess inventory it’s unable to sell.

Why did the Nanosonics share price drop 16%?

As a result of the transition to a new sales model, Nanosonics expects a $13 million to 16 million fall in FY22 revenue.

Consumables, which make up 80% of GE’s sales, will be unaffected.

However, capital sales of devices are expected to be impacted, leading to the revenue revisal.

While it’s a short term hit, the revenue drop has little to do with the underlying business. Rather, it’s a timing difference between purchases.

Going forward, the Nanosonics share price will benefit from reducing its reliance on GE for sales support, opting instead to insource its sales team.

The business will hire additional sales staff with a cost of $1 million in the second half.

By the start of 2022, Nanosonics will have a direct North American sales force of 100 staff.

“This sets up the organisation for ongoing success as we continue to grow our trophon franchise and plan to introduce new products to market”

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Lachlan does not have a financial or commercial interest in any of the companies or funds mentioned.
Skip to content